TRThomas J. Roodsant

Thomas J. Roodsant

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Thomas J. Roodsant has a total of 84 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Monitoring of cryptosporidiosis: a shift in circulating Cryptosporidium hominis subtypes, the Netherlands, 2016 to 2024

    by Thomas J Roodsant, Sietze Brandes, Alewijn Ott, Ingrid Hm Friesema, Roan Pijnacker, Jorrit J Hofstra

    BACKGROUND: Protozoan parasites Cryptosporidium spp. are important causes of gastrointestinal disease. They can cause large outbreaks. In the Netherlands, cryptosporidiosis is not notifiable, and monitoring relies on voluntary laboratory reporting. AIM: We aimed to describe the epidemiology of human cryptosporidiosis in the Netherlands from 2016 to 2024 and investigate associations with subtype and meteorological variables. METHODS: Three medical microbiology laboratories submitted faecal or DNA samples from patients with laboratory-confirmed cryptosporidiosis, with information about age and sex, for species identification and optional gp60 subtyping. Associations between numbers of infected patients and Cryptosporidium species, gp60 subtype, temperature and precipitation were analysed. RESULTS: In 2016–2024, 2,500 patients had laboratory-confirmed cryptosporidiosis, with a marked peak in 2023 (n = 622) caused by C. hominis . The lowest number of Cryptosporidium infections was recorded in 2021 (n = 61), with no C. hominis . Among all age groups, children aged ≤ 4 years had the highest number of infections (n = 493; 27%). In total, 1,166 (55%) patients had C. hominis and 951 (45%) had C. parvum infections. Infections with C. hominis peaked in September. We observed a weak association between temperature and the number of patients with C. hominis . Of the C. hominis identified , 207 were gp60 typed and an increase in subtype diversity was observed since 2022. CONCLUSION: In the Netherlands, C. hominis drives the annual fluctuations in cryptosporidiosis. Continuous surveillance, including information about exposure to risk factors and molecular typing, is key to a better understanding of the underlying causes of Cryptosporidium spp. infections.

  • Open Access

    Retrospective Surveillance of Cryptosporidium Species, Giardia Lamblia and Entamoeba Histolytica in the Netherlands (2015-2024): Epidemiological Trends and Disease Burden Updates

    by Elise M. J. Groenen, Thomas J. Roodsant, Alaa Al-Dawaf, Nicolaas L. A. Arents, Aldert Bart, Guido J. H. Bastiaens, M.S. Berends, Kim J. M. van Bergen, Danielle Hanssen, David J. Hetem, et al.

    Background: Cryptosporidium species and Giardia lamblia are endemic gastrointestinal pathogens worldwide, whereas Entamoeba histolytica is less commonly endemic, but can cause invasive disease. Due to limited surveillance of these parasites, epidemiological data in the Netherlands are scarce. Hence, we conducted a retrospective analysis of Nucleic Acid Amplification Test (NAAT) results to assess the incidence, disease burden, seasonality, and epidemiological trends of these infections.Methods: This retrospective, nationally representative cohort study analysed NAAT results from 24 medical microbiology laboratories (MMLs) (2015–2024) to estimate the incidence of Cryptosporidium species, G. lamblia, and E. histolytica, and to quantify the disease burden of human cryptosporidiosis and giardiasis in disability-adjusted life years (DALY) in the Netherlands. The study included all individuals tested for these parasites at participating MMLs. National incidence was estimated by extrapolating the population covered by MMLs, using NAAT-to-population ratios from six laboratories with known catchment sizes.Findings: A total of 9,373 Cryptosporidium species, 20,898 G. lamblia and 417 E. histolytica cases were identified, leading to an estimated mean incidence of 9.75 (95% CI: 9.56–9.95), 21.80 (21.40–22.00) and 0.43 (0.39–0.48) per 100,000 population, respectively. The annual disease burden (undiscounted DALYs) ranged from 74 (95% CI: 28-143) to 378 (95%CI: 150-694) for cryptosporidiosis (2020–2023), and from 233 (131–442) to 500 (275–950) for giardiasis (2021–2019). Cryptosporidium species and G. lamblia infections peaked in summer/fall and were most common in children, while E. histolytica incidence was low, non-seasonal, and significantly higher in men, affecting both children and adults.Interpretation: The persistently high disease burden of giardiasis and the recent, strong seasonal rise in cryptosporidiosis, highlight the need for enhanced surveillance, including genotyping and travel history, to guide public health interventions. Although E. histolytica incidence is low, its potential severity may warrant targeted measures such as contact tracing.


  • Open Access

    A conserved glycan motif induces broadly reactive functional antibodies against the zoonotic pathogen Streptococcus suis

    by Yao Shi, Göran Widmalm, Charlotte Sorieul, Thomas J. Roodsant, Jeffrey S. Rush, Natalia Korotkova, Manouk Vrieling, Antonius A. C. Jacobs, Mirlin Spaninks, Ries Grommen, et al.

    Streptococcus suis is a largely neglected but emerging bacterial zoonotic pathogen of global concern for animal welfare, antibiotic resistance development, and human health. No effective vaccines are now available. Here, we identified and characterized the function and structure of two cell wall polysaccharide variants in pathogenic S. suis strains using genetic deletion and (heterologous) complementation, lectin staining, glycan composition analysis, and specialized NMR spectroscopy. Both glycan variants were anionic polymers that differed in the presence of glucose in the side chain as a result of allelic variation in a glycosyltransferase gene. Deletion of this variable glycosyltransferase revealed an identical glycan “core” and affected S. suis morphology and lysozyme resistance. Immunization of pigs with this core domain elicited antibodies that recognized antigenically diverse pathogenic S. suis strains and induced complement deposition on encapsulated pathogenic S. suis strains. This study provides valuable insights for developing next-generation glycoconjugate vaccines, whereby a single-glycan target could protect against the emerging zoonotic pathogen S. suis .


  • Open Access

    A conserved glycan motif overcomes antigenic variation inducing broadly reactive antibodies against the zoonotic pathogen Streptococcus suis

    by Yao Shi, Göran Widmalm, Charlotte Sorieul, Thomas J. Roodsant, Jeffrey S. Rush, Natalia Korotkova, Antonius A. C. Jacobs, Mirlin Spaninks, Ries Grommen, C. Coral Domínguez-Medina, et al.

    Streptococcus suis is a largely neglected but emerging bacterial zoonotic pathogen of global concern for animal welfare, antibiotic resistance development and human health. No effective vaccines are currently available. Here, we identified and characterized the function and structure of two cell wall polysaccharide variants in pathogenic S. suis strains using genetic deletion and (heterologous) complementation, lectin staining, glycan composition analysis and specialized NMR spectroscopy. Both glycan variants were anionic polymers that differed in the presence of glucose in the side-chain as a result of allelic variation in a glycosyltransferase gene. Deletion of this variable glycosyltransferase revealed an identical glycan ‘core’ and affected S. suis morphology and lysozyme resistance. Immunization of pigs with this core domain induced antibodies recognizing a wide range of antigenically-diverse pathogenic S. suis strains. This study provides new insights for developing next-generation glycoconjugate vaccines, whereby a single-glycan target could protect against the emerging zoonotic pathogen S. suis .

  • Open Access

    Translocation across a human enteroid monolayer by zoonotic Streptococcus suis correlates with the presence of Gb3-positive cells

    by Thomas J. Roodsant, Kees C.H. van der Ark, Constance Schultsz


  • Open Access

    The streptococcal phase-variable type I restriction modification system SsuCC20p dictates the methylome of Streptococcus suis impacting the transcriptome and virulence in a zebrafish larvae infection model

    by Thomas J. Roodsant, Boas van der Putten, Jaime Brizuela, Jordy P. M. Coolen, Tim J. H. Baltussen, Kim Schipper, Yvonne Pannekoek, Kees C. H. van der Ark, Constance Schultsz

    Phase-variable type I restriction modification (RM) systems are epigenetic regulatory systems that have been identified in numerous human bacterial pathogens. We previously showed that an emerging zoonotic lineage of Streptococcus suis acquired a phase-variable type I RM system, named SsuCC20p. The SsuCC20p locus was identified in the genome of multiple streptococcal species, indicating that it is not restricted to S. suis and can be acquired through horizontal gene transfer. We demonstrate that SsuCC20p phase variability relies on a recombinase present within the locus. SsuCC20p is the single RM system responsible for the genome methylation profiles that were detected in the representative zoonotic S. suis isolate 861160 in vitro . In addition, we show that, contrary to previous observations, hsdS genes located downstream of hsdM and the recombinase gene contribute to the SsuCC20p genome methylation profile. SsuCC20p locked mutants expressing a single hsdS each show a unique genome methylation profile and, when grown in human serum, have distinct transcriptomes. In a zebrafish larvae infection model, we observed significant differences in virulence between the locked mutants and a corresponding shift in hsdS allele distribution in the wild type. These data indicate that the streptococcal phase-variable type I RM system SsuCC20p can impact bacterial fitness via epigenetic regulation of gene expression, which impacts the virulence of S. suis in the zebrafish larvae infection model. IMPORTANCE: Phase variation allows a single strain to produce phenotypic diverse subpopulations. Phase-variable restriction modification (RM) systems are systems that allow for such phase variation via epigenetic regulation of gene expression levels. The phase-variable RM system SsuCC20p was found in multiple streptococcal species and was acquired by an emerging zoonotic lineage of Streptococcus suis . We show that the phase variability of SsuCC20p is dependent on a recombinase encoded within the SsuCC20p locus. We characterized the genome methylation profiles of the different phases of SsuCC20p and demonstrated the consequential impact on the transcriptome and virulence in a zebrafish infection model. Acquiring mobile genetic elements containing epigenetic regulatory systems, like phase-variable RM systems, enables bacterial pathogens to produce diverse phenotypic subpopulations that are better adapted to specific (host) environments encountered during infection.


  • Open Access

    The streptococcal phase-variable Type I Restriction-Modification system SsuCC20p dictates the methylome of Streptococcus suis and impacts virulence

    by Thomas J. Roodsant, Boas van der Putten, Jaime Brizuela, Jordy P.M. Coolen, Tim J.H. Baltussen, Kim Schipper, Yvonne Pannekoek, Kees C.H. Van der Ark, Constance Schultsz

    Phase-variable Type I Restriction Modification (RM) systems are epigenetic regulatory systems that have been identified in numerous human bacterial pathogens. We previously showed that an emerging zoonotic lineage of Streptococcus suis acquired a phase-variable Type I RM system named SsuCC20p. The SsuCC20p locus was present in the genome of disease-associated isolates from multiple streptococcal species. This indicates that it is not restricted to S. suis and can be acquired through horizontal gene transfer. We demonstrate that SsuCC20p phase-variability relies on a recombinase present within the locus. In vitro , only SsuCC20p is responsible for the genome methylation profiles that were detected in the representative zoonotic S. suis isolate 861160. In addition, we show that, contrary to previous observations, hsdS genes located downstream of the hsdM gene and the recombinase gene, can contribute to the SsuCC20p genome methylation profile. SsuCC20p locked mutants expressing a single hsdS each showed unique genome methylation profiles. The differential genome methylation of the distinct locked mutants caused phase dependent differences in global gene expression in a growth condition dependent manner. We observed significant differences in virulence between hsdS locked mutants in a zebrafish larvae infection model. These data indicate that the streptococcal phase-variable Type I RM system SsuCC20p can impact bacterial virulence via epigenetic regulation of gene expression and potentially contributes to the zoonotic potential of S. suis . Importance: Phase-variation contributes to the virulence of bacterial pathogens as it allows a single strain to produce phenotypic diverse subpopulations. Phase-variable Restriction Modification (RM) systems are systems that allow for such phase-variation via epigenetic regulation of gene expression levels. The phase-variable RM system SsuCC20p was found in multiple streptococcal species and was acquired by an emerging zoonotic lineage of Streptococcus suis . We show that the phase-variability of SsuCC20p is dependent on a recombinase encoded within the SsuCC20p locus. We characterized the genome methylation profiles of the different phases of SsuCC20p and showed that the differential genome methylation within the phases causes differences in gene expression levels and virulence. Altogether, we show that the acquisition of a phase-variable RM system impacts virulence and can potentially contribute to the zoonotic potential of S. suis . Bacterial pathogens can increase their virulence through acquisition of mobile elements containing epigenetic regulatory systems such as RM systems.


  • Open Access

    Streptococcus suis outbreak caused by an emerging zoonotic strain with acquired multi-drug resistance in Thailand

    by Jaime Brizuela, Rattagan Kajeekul, Thomas J. Roodsant, Athita Riwload, Parichart Boueroy, Auttapong Pattanapongpaibool, Janjira Thaipadungpanit, Piroon Jenjaroenpun, Thidathip Wongsurawat, Elizabeth M. Batty, et al.

    Streptococcus suisis an emerging zoonotic swine pathogen which can cause severe infections in humans. In March 2021, an outbreak ofS. suisinfections with 19 confirmed cases of septicemia and meningitis leading to two deaths, occurred in Nakhon Ratchasima province, Thailand. We characterized the outbreak through an epidemiological investigation combined with Illumina and Nanopore whole genome sequencing (WGS). The source of the outbreak was traced back to a raw pork dish prepared from a single pig during a Buddhist ceremony attended by 241 people. WGS analysis revealed that a singleS. suisserotype 2 strain belonging to a novel sequence type (ST) of the emergent Thai zoonotic clade CC233/379, was responsible for the infections. The outbreak clone grouped together with other Thai zoonotic strains from CC233/379 and CC104 in a globalS. suisphylogeny and capsule switching events between serotype 2 zoonotic strains and serotype 7 porcine strains were identified. The outbreak strain showed reduced susceptibility to penicillin corresponding with mutations in key residues in the penicillin binding proteins (PBPs). Furthermore, the outbreak strain was resistant to tetracycline, erythromycin, clindamycin, linezolid and chloramphenicol, having acquired an integrative and conjugative element (ICE) carrying resistance genestetOandermB,as well as a transposon from the IS1216 family carryingoptrAandermA. This investigation demonstrates that multi-drug resistant zoonotic lineages ofS. suiswhich pose a threat to human health continue to emerge.


  • Open Access

    Correction for van der Putten et al., “Five Complete Genome Sequences Spanning the Dutch Streptococcus suis Serotype 2 and Serotype 9 Populations”

    by Boas C. L. van der Putten, Thomas J. Roodsant, Martin A. Haagmans, Constance Schultsz, Kees C. H. van der Ark

  • Open Access

    Identification of Streptococcus suis putative zoonotic virulence factors: A systematic review and genomic meta-analysis

    by Thomas J. Roodsant, Boas C.L. Van Der Putten, Sara M. Tamminga, Constance Schultsz, Kees C.H. Van Der Ark

    Streptococcus suis is an emerging zoonotic pathogen. Over 100 putative virulence factors have been described, but it is unclear to what extent these virulence factors could contribute to zoonotic potential of S. suis. We identified all S. suis virulence factors studied in experimental models of human origin in a systematic review and assessed their contribution to zoonotic potential in a subsequent genomic meta-analysis. PubMed and Scopus were searched for English-language articles that studied S. suis virulence published until 31 March 2021. Articles that analyzed a virulence factor by knockout mutation, purified protein, and/or recombinant protein in a model of human origin, were included. Data on virulence factor, strain characteristics, used human models and experimental outcomes were extracted. All publicly available S. suis genomes with available metadata on host, disease status and country of origin, were included in a genomic meta-analysis. We calculated the ratio of the prevalence of each virulence factor in human and pig isolates. We included 130 articles and 1703 S. suis genomes in the analysis. We identified 53 putative virulence factors that were encoded by genes which are part of the S. suis core genome and 26 factors that were at least twice as prevalent in human isolates as in pig isolates. Hhly3 and NisK/R were particularly enriched in human isolates, after stratification by genetic lineage and country of isolation. This systematic review and genomic meta-analysis have identified virulence factors that are likely to contribute to the zoonotic potential of S. suis.